GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » Pre-Tax Income

AFTPF (AFT Pharmaceuticals) Pre-Tax Income : $13.36 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. AFT Pharmaceuticals's pretax income for the six months ended in Mar. 2024 was $12.20 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $13.36 Mil. AFT Pharmaceuticals's pretax margin was 18.06%.

During the past 9 years, AFT Pharmaceuticals's highest Pretax Margin was 14.39%. The lowest was -26.49%. And the median was 6.97%.


AFT Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for AFT Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Pre-Tax Income Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only 7.80 5.63 12.83 9.81 13.39

AFT Pharmaceuticals Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.79 1.26 8.49 1.17 12.20

Competitive Comparison of AFT Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AFT Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Pre-Tax Income falls into.



AFT Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

AFT Pharmaceuticals's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=12.358+2.013+-2.242+0.04+1.225
=13.39

AFT Pharmaceuticals's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=11.329+1.581+-1.139+-0.283+0.708
=12.20

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $13.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AFT Pharmaceuticals  (OTCPK:AFTPF) Pre-Tax Income Explanation

AFT Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=12.196/67.546
=18.06%

During the past 9 years, AFT Pharmaceuticals's highest Pretax Margin was 14.39%. The lowest was -26.49%. And the median was 6.97%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AFT Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


AFT Pharmaceuticals Business Description

Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals Headlines